July 27th 2025, 2:00pm
By Ryan Scott
Self-compassion, emotional openness, and community support is incredibly important for patients currently beginning their cancer journey.
July 26th 2025, 6:00pm
By Spencer Feldman
Patients with essential thrombocythemia faced an average delay of 26.5 months between their first high platelet count and diagnosis.
July 26th 2025, 2:00pm
By Bren Ohta, PhD, MS, LCSW
After surviving brain surgery, I found clarity, strength, and unexpected joy; facing my fears became the turning point, not the diagnosis.
July 25th 2025, 9:00pm
By Brenda Ohta
After brain surgery for a malignant tumor, I faced fears, found strength, and embraced living in the moment as I begin treatment and healing.
July 25th 2025, 8:00pm
By Kimberly Demirhan
There is an urgent need for more inclusive and community-focused cancer clinical trials, according to Kimberly (Cary) Demirhan.
July 25th 2025, 7:00pm
New clinical trials are advancing treatments for cutaneous T-cell lymphoma, advanced solid tumors, pediatric sarcomas and ALK-positive lung cancer.
July 25th 2025, 5:00pm
By Bonnie Annis
When I was diagnosed with breast cancer, I never dreamed I’d learn so many valuable life lessons along the way.
July 25th 2025, 4:00pm
Food insecurity significantly increases the risk of death among cancer survivors, according to research published by Penn Medicine.
July 25th 2025, 3:00pm
Doptelet and new oral sprinkle granules is approved for children one year and older with chronic immune thrombocytopenia, showing 28% durable platelet response in study.
July 25th 2025, 1:00pm
Barbera credits Dr. Donna Klobocista’s compassionate guidance before surgery for giving her confidence; now she mentors others facing ovarian cancer.
July 24th 2025, 9:00pm
By Burt Rosen
A dual cancer diagnosis rewired how I live, love, and show up in the world — with presence, purpose, and unapologetic passion.
July 24th 2025, 8:00pm
By Dr. Weijing Sun
Dr. Weijing Sun discussed how GIST is typically diagnosed, as well as what tests are commonly used to confirm the diagnosis.
July 24th 2025, 7:37pm
By Igor Makhlin, MD
In this on-demand webinar series, Dr. Igor Makhlin discusses personalized treatment options for ER-positive, HER2-negative metastatic breast cancer, including the role of ESR1 mutation testing and targeted therapies like Orserdu.
July 24th 2025, 7:00pm
Fotivda preserved quality-of-life scores in kidney cancer, with better outcomes in second-line use and no added benefit from combining with Opdivo.
July 24th 2025, 5:00pm
By Felicia Mitchell
Hiking helped to sustain me through cancer treatment, with its emphasis on fresh air, natural wonders, and the companionship of friends.
FDA Grants Orphan Drug Designation to M2T-CD33 in AML
Some Advice for Cancer Caregivers During National Caregiver Month
Basal Cell Carcinoma Basics, From Diagnosis to Treatment
Stage 2 Cervical Cancer: Key Facts and Updates for Patients